The total clinical efficacy rate was 71%, and no serious adverse reactions were found.
临床总有效率71% ，未发现严重的不良反应。
ResultsThe overall clinical efficacy rate was 92.8%, no significant difference was found between male and female patients (P>0.05).
结果临床总有效率为92.8%，男女患者的临床疗效差异无显著性（P>0.05）。
The angina pectoris clinical efficacy rate has differences between two groups (P<0.05) for the treatment group is 90.0% and the control group is 70.0%.
心绞痛疗效比较显示试验组总有效率为90.0％，对照组总有效率为70.0％，组间对照无显著性差异（P＜0.05）；
Objective to evaluate the clinical therapeutic efficacy and safety of sibutramine to simple obesity and compare the effects of sibutramine and placebo on resting metabolic rate.
目的：评价西布曲明治疗单纯性肥胖病的临床疗效和安全性，并比较西布曲明和安慰剂对静息代谢率的影响。
Results The overall clinical and mycological efficacy rate was 96.67% and 96.7% respectively.
结果临床疗效评价和真菌疗效评价，总有效率分别为96.67%和96.7%。
The clinical efficacy and six-month recurrence rate were observed.
观察两组临床疗效和治愈病例六个月时的复发率。
Traditional symptoms of clinical efficacy total effective rate was 86.7%, significantly higher than the control group 63.3%, a significant difference between the two groups (P <0.05).
中医症候临床疗效方面治疗组总有效率为86.7%，明显优于对照组的63.3%，两组具有显著性差异（P<0.05）。
Observing the two groups with treatment safety, clinical efficacy, improvement of symptom score before and after treatment, and the follow-up relapsing rate.
观察两组治疗的安全性、临床疗效、治疗前后症状积分改善情况及随访复发情况。
Conclusion: DCIK combined with chemotherapy shows a better clinical efficacy in treatment of advanced lung cancer, with improved quality of life, immune function and survival rate.
结论：DCIK联合化疗治疗晚期肺癌具有更好的疗效，其生活质量、免疫功能和生存率有一定的提高。
Conclusion: DCIK combined with chemotherapy shows a better clinical efficacy in treatment of advanced lung cancer, with improved quality of life, immune function and survival rate.
结论：DCIK联合化疗治疗晚期肺癌具有更好的疗效，其生活质量、免疫功能和生存率有一定的提高。
应用推荐